Martin Mackay Charles River Laboratories International, Inc. (CRL) insider trading activity

Martin Mackay is Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 12,531 shares of CRL, which is worth approximately $2.61 Million. The most recent transaction as insider was on May 13, 2024, when has been sold 931 shares (Common Stock) at a price of $228.41 per share, resulting in proceeds of $212,649. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.5K

8.03% 3M change

8.92% 12M change

Total Value Held $2.61 Million

MARTIN MACKAY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2024	BUY Grant, award, or other acquisition	$212,649 $228.41 p/Share	931 Added 6.92%	12,531 Common Stock
Jul 03 2023	BUY Grant, award, or other acquisition	-	95 Added 0.81%	11,600 Common Stock
May 31 2023	BUY Grant, award, or other acquisition	-	338 Added 2.85%	11,505 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	664 Added 5.61%	11,167 Common Stock
May 11 2022	BUY Grant, award, or other acquisition	-	841 Added 7.41%	10,503 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	63 Added 0.65%	9,662 Common Stock
May 07 2021	BUY Grant, award, or other acquisition	-	574 Added 5.64%	9,599 Common Stock

Also insider at

FVAM

5:01 Acquisition Corp. Financial Services

Director

RLYB

Rallybio Corp Healthcare

Executive Chairman

Martin Mackay

Director

Wilmington, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Value

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL

Account